Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
301301 Yili Chuanning Biotechnology
- 14.02
- +2.34+20.03%
Market Closed May 15 15:00 CST
31.22BMarket Cap23.37P/E (TTM)
14.02High11.96Low1.48MlotVolume12.01Open11.68Pre Close1.99BTurnover23.97%Turnover Ratio22.29P/E (Static)2.23BShares16.5852wk High3.81P/B8.63BFloat Cap10.4152wk Low14.02Limit Up615.89MShs Float18.11Historical High9.34Limit Down17.64%Amplitude6.72Historical Low0.23Dividend TTM13.46Avg Price789.12KlotAsk1.60%Div YieldTTM100Lot Size632.45KlotBid
Yili Chuanning Biotechnology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 7.07%952.64M | 43.03%1.09B | -43.37%624.17M | -21.57%929.12M | -13.74%889.72M | -53.37%760.94M | 278.95%1.1B | 128.80%1.18B | --1.03B | 219.97%1.63B |
| Transactional financial assets | --190.33M | --0 | --613K | ---- | ---- | ---- | ---- | --0 | ---- | -4.80%1.15M |
| Notes receivable and accounts receivable | 19.10%978.37M | 25.56%939.3M | 13.59%1.03B | 0.66%937.99M | -19.57%821.45M | -14.76%748.09M | -15.35%907M | -4.44%931.86M | --1.02B | 12.39%877.6M |
| -Accounts receivable | 19.10%978.37M | 25.56%939.3M | 13.59%1.03B | 0.66%937.99M | -19.57%821.45M | -14.76%748.09M | -15.35%907M | -4.44%931.86M | --1.02B | 12.39%877.6M |
| Other receivables (including interest and dividends) | -37.63%863.9K | -15.82%531.44K | -31.12%1.38M | -25.96%1.4M | -17.33%1.39M | -75.64%631.29K | -18.01%2.01M | 27.42%1.89M | --1.68M | 117.74%2.59M |
| -Other receivable | ---- | ---- | ---- | -25.96%1.4M | ---- | -75.64%631.29K | ---- | 27.42%1.89M | ---- | 117.74%2.59M |
| Advance payment | -20.03%104.8M | 98.46%89.11M | -8.13%331.33M | -5.19%104.6M | -0.66%131.04M | -47.17%44.9M | 4.24%360.64M | -0.24%110.33M | --131.91M | 38.16%84.99M |
| Inventories | -14.25%1.17B | -19.95%1.34B | 2.28%896.83M | -0.54%920.62M | 27.56%1.36B | 21.16%1.68B | -20.73%876.82M | -24.32%925.62M | --1.07B | -4.81%1.38B |
| Receivable financing | -13.75%960.46M | -3.42%632.97M | 79.93%1.15B | 79.64%1.13B | 28.13%1.11B | 21.48%655.4M | -18.53%640.75M | 15.07%628.07M | --869.04M | 35.81%539.5M |
| Other current assets | 21.92%62.16M | -25.89%51.9M | 97.46%50.6M | 360.54%58.14M | 663.00%50.98M | 1,020.40%70.04M | 741.80%25.63M | 336.25%12.62M | --6.68M | -41.05%6.25M |
| Total current assets | 1.09%4.42B | 4.75%4.14B | 4.42%4.09B | 7.51%4.08B | 5.81%4.37B | -12.62%3.96B | 8.56%3.91B | 12.38%3.79B | --4.13B | 40.78%4.53B |
| Non Current assets | ||||||||||
| Other equity investment | -0.47%24.88M | --24.88M | --25M | --25M | --25M | ---- | ---- | ---- | ---- | ---- |
| Other non-current financial assets | --30M | --30M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Long-term equity investment | 461.84%37.9M | 132.98%15.8M | 137.69%16.22M | 139.97%16.48M | -2.28%6.74M | -2.10%6.78M | 70.90%6.82M | --6.87M | --6.9M | --6.93M |
| Fixed assets | ---- | ---- | ---- | -5.98%4.92B | ---- | -5.96%5.14B | ---- | -7.75%5.23B | ---- | -6.05%5.47B |
| Constru in process | ---- | ---- | ---- | 473.17%753.83M | ---- | 794.48%537.8M | ---- | 253.34%131.52M | ---- | -37.62%60.12M |
| Intangible assets | -8.11%231.04M | -8.59%235.83M | -8.89%241M | -9.44%245.48M | -9.43%251.45M | -8.86%257.99M | -8.67%264.53M | -8.48%271.08M | --277.64M | 4.13%283.07M |
| Development expenditure | --1M | --0 | ---- | ---- | ---- | ---- | ---- | --940.18K | ---- | ---- |
| Goodwill | 0.00%1.37M | 0.00%1.37M | 0.00%1.37M | 0.00%1.37M | 0.00%1.37M | 0.00%1.37M | 0.00%1.37M | 0.00%1.37M | --1.37M | 0.00%1.37M |
| Long deferred expense | -40.00%1.32M | -36.36%1.54M | -33.33%1.76M | -30.77%1.98M | -28.57%2.2M | -29.02%2.42M | -29.39%2.63M | -29.70%2.85M | --3.07M | -27.88%3.4M |
| Deferred tax assets | 4.77%22.31M | -3.47%20.9M | 41.38%28.26M | 62.40%27.05M | 69.29%21.3M | 90.99%21.65M | 116.31%19.99M | 72.62%16.65M | --12.58M | 62.92%11.34M |
| Usufruct assets | 153.38%481.59M | 153.75%485.99M | 162.43%507.5M | 138.62%502.29M | -11.65%190.07M | 1,582.76%191.52M | 1,528.99%193.38M | 1,602.92%210.5M | --215.14M | 179.33%11.38M |
| Other non current assets | 30.71%32.67M | 53.65%33.25M | -71.92%47.55M | -73.42%23.83M | -26.45%24.99M | 20.45%21.64M | 280.13%169.34M | 98.45%89.67M | --33.98M | -56.11%17.97M |
| Total non current assets | 1.79%6.32B | 3.67%6.41B | 5.49%6.46B | 9.26%6.52B | 3.67%6.21B | 5.45%6.18B | 2.82%6.13B | -1.88%5.97B | --5.99B | -6.13%5.86B |
| Total assets | 1.50%10.73B | 4.09%10.55B | 5.07%10.55B | 8.58%10.6B | 4.55%10.57B | -2.42%10.14B | 4.99%10.04B | 3.21%9.76B | --10.11B | 9.82%10.39B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -75.30%210.15M | -75.30%210.15M | -51.38%320.18M | 10.46%750.6M | -3.38%850.75M | -13.09%850.68M | -21.66%658.47M | -19.17%679.53M | --880.52M | 39.76%978.83M |
| Transactional financial liabilities | ---- | ---- | ---- | -93.96%256.1K | -49.14%551.43K | --31.5K | -77.66%665.89K | 316.82%4.24M | --1.08M | --0 |
| Notes payable and accounts payable | -18.49%803.12M | -11.38%895.44M | -8.97%689M | 20.49%783.99M | 68.23%985.26M | 36.45%1.01B | 20.13%756.93M | 8.32%650.65M | --585.65M | -20.13%740.5M |
| -Notes payable | -48.89%150M | -48.89%150M | ---- | --0 | --293.46M | 166.79%293.46M | -36.36%70M | --70M | ---- | -57.04%110M |
| -Accounts payable | -5.59%653.12M | 3.97%745.44M | 0.30%689M | 35.02%783.99M | 18.12%691.79M | 13.71%716.96M | 32.08%686.93M | -3.34%580.65M | --585.65M | -6.05%630.5M |
| Contract liabilities | -51.21%27.01M | 130.86%66.82M | -0.41%77.65M | -86.26%18.42M | 356.11%55.36M | -23.84%28.94M | 706.35%77.97M | 887.83%134.06M | --12.14M | 78.73%38M |
| Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Salaries payable | 10.02%27.32M | 23.52%36.98M | 15.94%26.69M | 9.92%26.29M | 10.31%24.83M | 13.04%29.94M | 31.87%23.02M | 11.43%23.92M | --22.51M | 31.08%26.48M |
| Taxs payable | -5.33%132.36M | 168.02%103.01M | 24.61%117.14M | 14.19%118.06M | 102.66%139.8M | -26.34%38.43M | 71.79%94M | 129.13%103.39M | --68.98M | 5,869.63%52.18M |
| Other payable (including interest and dividends) | -14.19%28.85M | -60.39%12.54M | 118.43%61.92M | 66.70%56.78M | 27.01%33.62M | 82.85%31.66M | 908.80%28.35M | 59.27%34.06M | --26.47M | 61.30%17.32M |
| -Interest payable | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| -Dividend payable | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| -Other payable | ---- | ---- | ---- | 66.70%56.78M | --33.62M | 82.85%31.66M | ---- | 59.27%34.06M | ---- | 61.30%17.32M |
| Non current liabilities due within one year | 93.37%740.58M | 13.81%617.06M | -8.25%699.54M | -52.02%365.96M | -55.10%382.99M | -36.15%542.16M | 21.23%762.47M | 21.26%762.79M | --853.06M | -3.42%849.13M |
| Other current liabilities | -61.89%2.68M | 61.20%5.55M | -51.34%4.88M | -89.06%1.9M | 346.38%7.02M | -30.31%3.44M | 702.46%10.04M | 891.28%17.37M | --1.57M | 58.13%4.94M |
| Total current liabilities | -20.49%1.97B | -23.20%1.95B | -17.20%2B | -11.94%2.12B | 1.15%2.48B | -6.34%2.54B | 10.21%2.41B | 10.82%2.41B | --2.45B | 5.64%2.71B |
| Current liabilities | ||||||||||
| Long term loan | --0 | -59.14%146M | -43.24%393M | -6.11%650M | -52.79%483M | -74.98%357.33M | -69.00%692.33M | -69.00%692.33M | --1.02B | -31.74%1.43B |
| Estimate liabilities | 115.63%3.04M | ---- | 2.64%5.47M | -5.84%3.22M | -43.84%1.41M | --77.9K | --5.33M | --3.41M | --2.51M | --0 |
| Deferred tax liabilities | ---- | ---- | -83.86%142.43K | -84.12%94.56K | -97.09%20.7K | 268.49%307.28K | --882.58K | --595.63K | --712.39K | --83.39K |
| Long term deferred income | 14.85%94.56M | 10.47%92.51M | 13.11%93.5M | 71.57%94.56M | 148.16%82.34M | 144.56%83.74M | 246.14%82.66M | 123.37%55.11M | --33.18M | 30.59%34.24M |
| Lease liabilities | 135.24%455.67M | 139.81%451.12M | 154.20%473.06M | 129.31%458.29M | -10.67%193.7M | 1,743.84%188.12M | 1,681.27%186.09M | 1,779.90%199.86M | --216.83M | 226.35%10.2M |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Total non current liabilities | -27.25%553.28M | 9.54%689.63M | -0.22%965.17M | 26.79%1.21B | -40.41%760.47M | -57.25%629.58M | -57.34%967.3M | -58.06%951.32M | --1.28B | -30.59%1.47B |
| Total liabilities | -22.07%2.53B | -16.69%2.64B | -12.34%2.96B | -0.98%3.33B | -13.08%3.24B | -24.27%3.17B | -24.16%3.38B | -24.35%3.36B | --3.73B | -10.77%4.18B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.20%2.23B | 0.20%2.23B | 0.20%2.23B | 0.20%2.23B | 0.00%2.22B | 0.00%2.22B | 11.14%2.22B | 11.14%2.22B | --2.22B | 11.14%2.22B |
| Capital reserve funds | 0.86%3.29B | 1.00%3.28B | 1.16%3.28B | 1.34%3.28B | 0.91%3.26B | 0.69%3.25B | 33.45%3.24B | 33.09%3.23B | --3.23B | 32.87%3.23B |
| Surplus reserve funds | 88.79%325.32M | 88.79%325.32M | 132.85%172.32M | 132.85%172.32M | 132.85%172.32M | 132.85%172.32M | 117.80%74M | 117.80%74M | --74M | 117.80%74M |
| Retained profit | 40.98%2.35B | 56.88%2.06B | 69.98%1.89B | 83.21%1.58B | 95.20%1.67B | 93.71%1.31B | 73.96%1.11B | 58.56%862.36M | --853.66M | 121.12%678.21M |
| Less:Treasury stock | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Other composite income | ---99.34K | ---99.34K | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Ordinary risk reserve funds | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Specific reserves | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Shareholders equity without minority interests | 11.86%8.19B | 13.46%7.9B | 13.81%7.57B | 13.51%7.26B | 14.74%7.32B | 12.18%6.96B | 30.34%6.65B | 27.67%6.39B | --6.38B | 30.04%6.2B |
| Minority interests | 46.06%18.82M | 46.28%18.83M | 73.32%18.84M | 114.86%12.9M | 114.65%12.88M | 114.47%12.87M | 81.12%10.87M | -0.00%6M | --6M | -0.01%6M |
| Total shareholder equity | 11.92%8.21B | 13.52%7.92B | 13.90%7.59B | 13.60%7.27B | 14.83%7.33B | 12.28%6.97B | 30.40%6.66B | 27.63%6.4B | --6.39B | 30.00%6.21B |
| Total liabilityies and equity | 1.50%10.73B | 4.09%10.55B | 5.07%10.55B | 8.58%10.6B | 4.55%10.57B | -2.42%10.14B | 4.99%10.04B | 3.21%9.76B | --10.11B | 9.82%10.39B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting